Use of Low-Molecular-Weight Heparins and New Anticoagulants in Elderly Patients with Renal Impairment

Author： >  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.3, 2011-03, pp. : 177-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Anticoagulant Activity of Low-Molecular-Weight Heparins

By Stolbushkina P. P.   Bannikova G. E.   Drozd N. N.   Makarov V. A.   Varlamov V. P.   Vikhoreva G. A.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 2, 2004-02 ,pp. : 82-85

Springer Publishing Company

Access to resources Recommend Favorite

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Structure-Activity Relationships of Low Molecular Weight Heparins Expose to the Risk of Achieving Inappropriate Targets in Patients with Renal Failure

By  

Current Medicinal Chemistry, Vol. 16, Iss. 23, 2009-08 ,pp. : 3028-3040

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease

By Gallieni Maurizio  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 773-774

Adis International

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins: Mechanisms, Trials, and Role in Contemporary Interventional Medicine

By Canales John F.   Ferguson James J.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 15-25

Adis International

Access to resources Recommend Favorite